Tag: CBT > Cannabis DEA: Page 4

Interviews & Opinion

Rescheduling Update: How Long Is the Wait? What’s Next?

Government affairs and policy expert David Mangone tells us what we can expect from the DEA as weeks pass following the public comment period, including insights on the DEA’s final review and if a hearing is likely to be granted.

August 8, 2024

Cannabis Rescheduling

Cannabis Rescheduling Nearly ‘Done Deal,’ Story Cannabis CEO Says

Jason Vedadi, the former executive chairman for Harvest Health before its acquisition by Trulieve, talks exclusively with CBT on what he expects from federal rescheduling as the industry awaits the DEA’s final determination.

July 29, 2024

Cannabis Rescheduling

43,000 Comments Filed on Cannabis Rescheduling Proposal as Public Period Closes

The Drug Enforcement Administration will now weigh these comments and potentially hold administrative law hearings before issuing a final rule.

July 23, 2024

Cannabis Rescheduling

9 US Senators Urge VA to Expand Access to Medical Cannabis for America’s Veterans

Sen. Jeff Merkley led the group in a letter to U.S. Secretary of Veterans Affairs Denis McDonough following the DEA’s rescheduling recommendation.

July 19, 2024

Kentucky

Kentucky Governor Urges DEA to Reschedule: ‘The Jury is No Longer Out on Marijuana’

Gov. Andy Beshear wrote a letter to DEA Administrator Anne Milgram expressing his support for reclassifying cannabis to a Schedule III substance.

July 17, 2024

Federal Cannabis Legalization

25 GOP Lawmakers Condemn Cannabis Rescheduling in New Letter

Sen. James Lankford and Rep. Pete Sessions spearheaded the letter sent to Attorney General Merrick Garland, saying rescheduling lacks “adequate science.”

July 12, 2024

Cannabis Rescheduling

US Congressmen Press DEA Head to Explain Her Signature Absence on Cannabis Rescheduling Document

The agency’s administrator, Anne Milgram, did not personally approve the notice of proposed rulemaking to reclassify cannabis on May 16.

May 23, 2024

Banking Services Cannabis Industry

Federal Marijuana Rescheduling on the Horizon: A Big Step Forward But Not the Be-All-End-All

Rescheduling does not make cannabis legal throughout America and the U.S. territories; It makes cannabis a federally regulated medication—and many questions remain about the fate of the industry.

May 23, 2024

Cannabis Rescheduling

Cannabis Industry Reacts to Biden’s Rescheduling Announcement

The President’s May 16 announcement is being touted as an important and historic first step, but many industry constituents say there’s still a long way to go, with social justice at the heart of pushes for decriminalization. Here are reactions from cannabis business executives, industry organizations, lawyers and members of Congress.

May 17, 2024

Oklahoma

DEA 2024 Report Focuses on THC Potency, Organized Crime, Youth Edible Consumption

The federal agency’s National Drug Threat Assessment calls attention to how scheduled substances and trafficking trends are “endangering” the U.S.

May 17, 2024

Cannabis Rescheduling

White House Moves to Reschedule Cannabis in ‘Monumental’ Decision, Biden Says

The Department of Justice will issue a notice of proposed rulemaking to reclassify cannabis in the Federal Register, which will be followed by a 60-day public comment period prior to the department potentially finalizing the rule.

May 16, 2024

Cannabis Rescheduling

Cannabis Rescheduling Reactions Mixed: While Some Applaud Potential, Others Push For More

Executives, lawmakers and nonprofit leaders weigh in on the significance and shortcomings of the DEA's move to reclassify cannabis as a less dangerous substance.

May 1, 2024